Quarterly Results for second quarter and half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Smruthi Organics reported unaudited results for Q2 FY26 and H1 FY26. Q2 revenue from operations rose 7.5% year-on-year to Rs. 3,159.52 lakhs (vs Rs. 2,939.10 lakhs in Q2 FY25), but H1 revenue declined about 10.7% to Rs. 5,068.73 lakhs versus Rs. 5,666.37 lakhs in H1 FY25. Net profit for Q2 jumped to Rs. 205.62 lakhs from Rs. 77.51 lakhs a year ago, and H1 swung from a Rs. 14.79 lakh loss to a Rs. 96.07 lakh profit. Q2 EPS stood at Rs. 1.80 versus Rs. 0.68. The API (bulk drugs) segment drove the turnaround, while the smaller Formulations division continued to post a loss of Rs. 16.72 lakhs in H1. Operating cash flow was strong at Rs. 1,703.48 lakhs in H1, and the company reduced both short-term and long-term borrowings.
Sharp sequential and YoY recovery in profitability, better margins, and deleveraging are positive for shareholders, though the H1 topline decline and continued losses in Formulations may temper enthusiasm. Overall, the print is constructive for the stock.